OKLAHOMA CITY, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cytovance Biologics, Inc. (Cytovance), a leading full-service contract development and manufacturer of...

Oklahoma City, OK July 24, 2017- Cytovance hosted an unannounced FDA inspection Tuesday, July 11th, 2017. The inspector conducted the...

Oklahoma City, OK – March 14, 2017- Cytovance® Biologics, a leading CDMO who provides unparalleled support to biopharmaceutical companies to...

Oklahoma City, OK – January 13, 2017 - Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and...

EDMONTON, ALBERTA, December 7, 2016 – OncoQuest Inc. (“OncoQuest’), a biopharmaceutical company focused on the development and commercialization of immunotherapeutic...

OKLAHOMA CITY, OK - November 29, 2016 - Cytovance® Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial...

Oklahoma City, OK – September 13, 2016 - Cytovance® Biologics, Inc., a leading biopharmaceutical contract manufacturing organization announces the appointment...

Oklahoma City, OK – August 9, 2016 - Cytovance® Biologics, Inc., a leading biopharmaceutical contract manufacturing organization announces the appointment...

Oklahoma City, OK - February 17, 2016 - Cytovance® Biologics, Inc. a leading full-service contract manufacturer of mammalian and microbial...

Oklahoma City, OK - November 17, 2015– Cytovance® Biologics, Inc. announced that it has entered into a Development and Manufacturing...